AKIN GUMP STRAUSS HAUER & FELD for SHATTERPROOF
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of and funding for SUPPORT Act; legislation related to addressing the opioid crisis and additional addiction issues, including H.R. 2482/S. 2074, H.R. 3734/S. 1448, and S. 1012/H.R. 2062; education re Shatterproofs Addiction Treatment Locator, Analysis, and Standards (ATLAS) tool; addiction prevention and assistance efforts in the workplace; and advise client regarding federal legislative and regulatory response to the COVID-19 Cares Act and other federal initiatives as they relate to the quality of, and access to substance use disorder treatment.; Implementation of and funding for SUPPORT for Patients and Communities Act (P.L. 115-271); legislation related to addressing the opioid crisis and additional addiction issues, including the Mainstreaming Addiction Treatment Act (H.R. 2482/S. 2074); Medication Access and Training Expansion Act (H.R. 2482); PDMPs Help Patients Act of 2019 (H.R. 3927).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN JONAS | — |
| JULIE NOLAN New | Dep.CoS and LD, Nov.17-Nov. 18; LD, Nov.16-17; LA Oct. 15-16 to Rep. Patrick Meehan; Staff Asst, Sen. Richard Lugar Jan. 06-Jan. 07. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.